Aspen Pharmacare repurchases stock worth ZAR 1.98 billion

PUBT · 2d ago
Aspen Pharmacare repurchases stock worth ZAR 1.98 billion
  • Aspen Pharmacare repurchased 13,330,879 ordinary shares, about 3% of issued share capital, under its FY2026 buyback mandate.
  • Purchases ran from May 29 to Aug. 31 at an average R 148.17 per share, for total consideration of R 1.98 billion.
  • Shares were bought between R 137.5 and R 160, funded from available cash resources.
  • JSE delisting and cancellation is expected around Sept. 15, 2026; Aspen will hold 15,273,687 treasury shares post-buyback.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspen Pharmacare Holdings Ltd. published the original content used to generate this news brief via SENS, the regulatory disclosure system operated by the Johannesburg Securities Exchange (JSE) (Ref. ID: S602554), on September 02, 2026, and is solely responsible for the information contained therein.